SynapDx Receives $9,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    Undisclosed Waltham, MA 02451
  • Company Description
    SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company will use the proceeds to continue development of a diagnostic testing system for the early detection of autism.
  • M&A Terms
  • Venture Investor
    Bain Capital Ventures
  • Venture Investor
    General Catalyst Partners
  • Venture Investor
    North Bridge Venture Partners